You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 14, 2025

Drugs in MeSH Category Antiperspirants


✉ Email this page to a colleague

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novatech Sa STERITALC talc POWDER;INTRAPLEURAL 205555-002 May 1, 2017 RX Yes No ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Sciarra Labs TALC talc POWDER;INTRAPLEURAL 021388-001 Dec 15, 2003 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Sciarra Labs SCLEROSOL talc AEROSOL;INTRAPLEURAL 020587-001 Dec 24, 1997 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
Novatech Sa STERITALC talc POWDER;INTRAPLEURAL 205555-003 May 1, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Antiperspirants Market Analysis and Financial Projection

The antiperspirant market is experiencing robust growth driven by innovation, shifting consumer preferences, and regional dynamics. Below is an analysis of its market dynamics and patent landscape, supported by data from clinical studies, industry reports, and patent filings.


Market Growth and Projections

The global antiperspirant and deodorant market is valued at USD 62.8 billion in 2023, with projections to reach USD 81.9 billion by 2031, growing at a 3.36% CAGR[18]. Alternative estimates suggest a higher growth trajectory, targeting USD 100 billion by 2028 (6.5% CAGR) due to urbanization and hygiene awareness[2]. North America dominates the market, driven by premium product demand, while Asia-Pacific emerges as the fastest-growing region due to rising disposable incomes and urbanization[2][18]. Europe prioritizes sustainability, with 40% of consumers opting for eco-friendly formulations[2].


Key Consumer Trends

  • Natural and Aluminum-Free Products: Demand for aluminum-free antiperspirants surged by 22% in 2025, driven by health concerns and clean beauty movements[16].
  • Advanced Formulations: Brands like Degree introduced 72-hour sweat-control microtechnology, reducing reapplication needs[16].
  • Sustainability: Over 60% of European consumers favor recyclable packaging, pushing brands to adopt biodegradable materials[2][18].

Patent Innovations

Recent patents highlight breakthroughs in formulation safety and efficacy: Patent Focus Innovation Example
Aluminum Alternatives Chitosan-based antiperspirants reducing sweat without aluminum[5][10] Patent 11,154,485: Blocks sweat glands using chitosan[5]
Fragrance Delivery Inorganic-shell capsules preventing perfume leakage[17] Patent 11,938,349: Enhanced perfume stability in antiperspirants[17]
Suspension Stability Hydrophobic clay minerals and rice starch improving product texture[5][13] Patent 11,103,426: Non-streaking, long-lasting formulas[5]

Challenges and Controversies

  • Aluminum Safety: While systemic absorption is low, debates persist about links to Alzheimer’s and breast cancer[10].
  • Regulatory Compliance: The FDA’s 2021 monograph mandates safety evaluations for OTC antiperspirants[7].
  • Environmental Impact: Plastic packaging accounts for 30% of landfill waste, prompting shifts to refillable containers[2][8].

Regional Dynamics

  • North America: Premium products like clinical-strength antiperspirants dominate, with 85% efficacy in sweat reduction[1][9].
  • Asia-Pacific: Growth centers on budget-friendly options, with 15% annual sales increases in India and China[2].
  • Europe: Aluminum-free products claim 35% market share, driven by strict EU regulations on fragrances and preservatives[6][18].

Future Outlook

By 2030, AI-driven personalization and probiotic-infused formulas targeting axillary microbiota imbalances will reshape the industry[11]. Meanwhile, patent filings for aluminum-zirconium complexes and pH-balanced gels signal a focus on skin compatibility[13][16]. The market’s evolution hinges on balancing efficacy, safety, and sustainability, with USD 1.2 billion invested in R&D in 2025 alone[14].


"Over-the-counter clinical-strength antiperspirants are now a viable alternative to prescription aluminum chloride, offering comparable efficacy with reduced irritation." – Clinical Study Summary[1].

This analysis highlights a sector poised for growth but constrained by regulatory and environmental pressures, with innovation centered on safety and sustainability.

References

  1. https://pubmed.ncbi.nlm.nih.gov/22385032/
  2. https://reads.alibaba.com/antiperspirant-deodorant-understanding-its-benefits-and-choices/
  3. https://www.cognitivemarketresearch.com/antiperspirant-and-deodorant-market-report
  4. https://www.cognitivemarketresearch.com/deodorant-antiperspirant-market-report
  5. https://patents.justia.com/patents-by-us-classification/424/65
  6. https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_102.pdf
  7. https://pubmed.ncbi.nlm.nih.gov/12795305/
  8. https://www.coherentmarketinsights.com/market-insight/deodorant-and-antiperspirant-market-4690
  9. https://pubmed.ncbi.nlm.nih.gov/30249082/
  10. https://pubmed.ncbi.nlm.nih.gov/32248967/
  11. https://pubmed.ncbi.nlm.nih.gov/33644863/
  12. https://www.science.gov/topicpages/g/gel+combination+topically
  13. https://patents.google.com/patent/US5135741A/en
  14. https://www.marketresearchintellect.com/blog/the-battle-against-sweat-innovations-shaping-the-antiperspirant-market/
  15. https://patents.google.com/patent/US20110256082A1/en
  16. https://reads.alibaba.com/understanding-deodorant-antiperspirant-a-comprehensive-guide/
  17. https://patents.justia.com/patent/11938349
  18. https://www.snsinsider.com/reports/antiperspirants-and-deodorants-market-1008
Last updated: 2025-03-24

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.